Assosiate Professor
EPFL, The Swiss Federal Institute of Technology of Lausanne
Lausanne, Vaud, Switzerland
• Studies in Biochemistry and Organic Chemistry at JWG-University Frankfurt, Germany
• PhD on directed evolution of gene therapy vectors for cancer therapy at the Paul-Ehrlich-Institut Langen, Germany
• Postdoctoral work on high throughput screening in droplet formats at the MRC Laboratory of Molecular Biology (LMB, 13 Nobel Prizes) in Cambridge, UK
• Senior Postdoc and Junior Group Leader at the Institut de Science et d’Ingenierie Supramoleculaire, Strasbourg France (founded by Nobel Laureate Jean-Marie Lehn)
• Group Leader at EMBL Heidelberg
• Since 2020: Professor for Biomedical Microfluidics at the Swiss Federal Instute for Technology, Lausanne (EPFL)
• Sole scientific founder of Velabs Therapeutics (Heidelberg 2017; now operating as Veraxa Biotech) and Co-founder of TheraMe AG (Lausanne 2023)
Disclosure information not submitted.
Wednesday, May 29, 2024
15:00 – 15:30 CEST